NCT05465681 2023-04-12
Study of HR20013 for Injection in Patients With Malignant Solid Tumors
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 1 Completed
Clinical Trials
1 trialsPhase 1 × Completed × Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy × Clear all